RNOtherInternational journal of nursing practice2026

Development and Preliminary Testing of the Healthy Transition Scale for Patients Undergoing Haemodialysis.

Ae-Kyung Chang, Min-Kyung Kim, Woo-Jung Hong and 2 others

PMID 42056020

WHAT IT FOUND

A 19-item questionnaire rates how well patients starting haemodialysis adjust to treatment.

Higher scores suggest healthier transition, but it was developed only in Korean in-centre patients and has not been shown to improve care.

Key findings

01The final Healthy Transition Scale has 19 items in four factors: independent participation, subjective well-being, acceptance and integration, and active information seeking and coping.

02Total scores range from 19 to 95, and a higher total score indicates a healthier transition to haemodialysis.

03The scale was developed for in-centre haemodialysis patients in Korea, and its generalisability is limited until tested in home haemodialysis and other cultural backgrounds.

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The scale was developed only for in-centre haemodialysis patients in Korea, so it may not apply to home dialysis or other cultures. The study used convenience sampling from three hospitals, so the patients may not represent all haemodialysis patients. The scale was tested with exploratory factor analysis only, and confirmatory factor analysis has not been done in another sample. One subscale, active information seeking and coping, had lower internal consistency (0.67). This was a scale development and validation study, not a trial of using the scale in care.

Declared interests

Funded by the National Research Foundation of Korea (grant number 2021R1F1A1050087). The authors declare no conflicts of interest.

The easy way to misread this

Do not assume this scale is proven to improve patient care or outcomes. It was developed and preliminarily tested in Korean in-centre haemodialysis patients, and its usefulness for treatment decisions has not been established.

Read it on PubMed →